First Call for Science and Technology at ESC Congress 2018

ESC Congress 2018 Participate in the first ever ESC Digital Health Call for Technology, for the chance to present your innovations, your technology or your products at ESC Congress 2018 in front of an audience of relevant professionals. A dedicated Digital Health Area will feature a stage setting surrounded by Industry booths and meeting facilities, providing opportunities to exchange on latest digital health related innovations and research.

Selection Criteria

All proposals will be reviewed by the ESC's Digital Health Committee. Proposals of particular interest will be:
  • Relevant to clinical practice
  • Potentially impact the doctor/patient relationship
  • Support self management and self monitoring, or disease prevention
  • Facilitate remote data collection, remote monitoring, telemedicine or virtual consultation
  • Illustrate digital decision support systems, including artificial intelligence and associated technologies
  • Relevant to cardiovascular research or research methodology (e.g. remote data collection, digital patient reported outcome measurement)
  • Facilitate research or interpretation of results

The Technologies & solutions should be either on the market or "ready for market". Examples of technologies/approaches that can be illustrated with practical user cases, and ideally have outcome studies rather than just user numbers/satisfaction data, will be prioritised.

Deadline for Submission

Monday 11 June 2018, 23:59 (CEST - Central European Summer Time).

No late submission will be accepted.

For further information, please visit:
https://www.escardio.org/Congresses-&-Events/ESC-Congress/Call-for-Science/call-for-technology

Most Popular Now

Merck and Tencent Announce Collaboration…

Merck, a leading science and technology company, signed a strategic collaboration agreement with Tencent, a leading provider of Internet value added services. The collaboration will primarily focus on increasing public...

Merck Granted U.S. Patent for Novel Comb…

Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The patent relates...

Applications Now Open for Pioneering Dig…

The Yorkshire & Humber AHSN (Academic Health Science Network), in partnership with mHabitat, announces that applications for the 2019 Propel@YH digital health accelerator programme are now open. Propel@YH has been...

The European Health Catapult Program for…

Through dedicated sessions, a group of international top-level investors, key healthcare leaders and industry stakeholders work closely together challenging 40+ ambitious startups to optimize their business plan and strengthen their...

Flagship Axe the Fax Trust Rolls out Hyb…

Leeds Teaching Hospitals NHS Trust (LTHT), the organisation at the forefront of the national Axe the Fax campaign, is implementing an electronic fax solution to tackle its last remaining machines...

First EU Citizens Using ePrescriptions i…

The first EU patients can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country: Finnish patients are now able to go to a...

Final Report: Provision of a Market Stud…

The aim of the study is to examine the telemedicine market in Europe and to understand the factors that determine its development. The analysis maps telemedicine applications and solutions, and...

Open Access Drug Development Tools Featu…

New open access tools for drug development, obesity, and the environmental impacts of medicines are the focus of a new IMI2 Call for proposals launched today. The total budget of...

Boehringer Ingelheim (Canada) Ltd. and I…

Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology...

The NHS Long Term Plan: Cracking the Da …

Opinion Article by Prof. Michael Thick, Chief Medical Officer, Chief Clinical Information Officer, IMS MAXIMS Reading the NHS Long Term Plan this week, I had a definite sense of déjà vu...

Highland Marketing Advisory Board Respon…

The first meeting of Highland Marketing's newly expanded advisory board discussed the NHS Long Term Plan and what will be needed to make it a success. Structural change, leadership, investment...